Hang Su

1.5k total citations
54 papers, 1.1k citations indexed

About

Hang Su is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hang Su has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Hang Su's work include Lung Cancer Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (24 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Hang Su is often cited by papers focused on Lung Cancer Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (24 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Hang Su collaborates with scholars based in China, United States and Chile. Hang Su's co-authors include Yijiu Ren, Chang Chen, Yunlang She, Huikang Xie, Chenyang Dai, Dong Xie, Gening Jiang, Chunyan Wu, Hui Zheng and Erjia Zhu and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and CHEST Journal.

In The Last Decade

Hang Su

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hang Su China 18 640 220 185 164 127 54 1.1k
Lisa Deloch Germany 17 205 0.3× 280 1.3× 224 1.2× 428 2.6× 112 0.9× 31 991
Gianpaolo Vidili Italy 14 152 0.2× 98 0.4× 146 0.8× 212 1.3× 340 2.7× 29 970
Jungho Han South Korea 16 308 0.5× 64 0.3× 173 0.9× 107 0.7× 78 0.6× 43 853
Xiaochen Zhang China 16 138 0.2× 83 0.4× 156 0.8× 234 1.4× 79 0.6× 74 740
Hiroyuki Deguchi Japan 13 253 0.4× 57 0.3× 122 0.7× 153 0.9× 172 1.4× 59 665
Li Ma China 22 517 0.8× 420 1.9× 250 1.4× 297 1.8× 198 1.6× 99 1.3k
Pengfei Shen China 19 674 1.1× 60 0.3× 279 1.5× 216 1.3× 179 1.4× 96 1.1k
Hyunjin Kim South Korea 16 226 0.4× 24 0.1× 152 0.8× 227 1.4× 101 0.8× 69 687
Yunhai Yang China 17 369 0.6× 105 0.5× 173 0.9× 144 0.9× 89 0.7× 47 685

Countries citing papers authored by Hang Su

Since Specialization
Citations

This map shows the geographic impact of Hang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Su more than expected).

Fields of papers citing papers by Hang Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Su. The network helps show where Hang Su may publish in the future.

Co-authorship network of co-authors of Hang Su

This figure shows the co-authorship network connecting the top 25 collaborators of Hang Su. A scholar is included among the top collaborators of Hang Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hang Su. Hang Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Su, Hang, et al.. (2025). RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway. BMC Cancer. 25(1). 354–354. 1 indexed citations
3.
Li, Dongqing, Hang Su, Xiaolin Deng, et al.. (2025). DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated Mitophagy. International Journal of Biological Sciences. 21(4). 1530–1544. 3 indexed citations
4.
Xu, Long, Yue Zhao, Hang Su, et al.. (2024). Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma. The Annals of Thoracic Surgery. 118(4). 825–833. 5 indexed citations
6.
Fan, Junqiang, Jie Yao, Huikang Xie, et al.. (2023). Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas. Lung Cancer. 178. 123–130. 11 indexed citations
7.
Chen, Qiqing, Jiani Gao, Hairui Yu, et al.. (2022). An emerging role of microplastics in the etiology of lung ground glass nodules. Environmental Sciences Europe. 34(1). 124 indexed citations
8.
Gao, Jiani, Xiangyang Wu, Hang Su, et al.. (2022). CDK inhibitor Palbociclib targets STING to alleviate autoinflammation. EMBO Reports. 23(6). e53932–e53932. 46 indexed citations
9.
Luo, Shuaishuai, Feng Du, Hang Su, et al.. (2022). Superconductivity in non-centrosymmetric ZrNiAl and HfRhSn-type compounds. Journal of Physics Condensed Matter. 34(43). 435701–435701. 2 indexed citations
10.
Huang, Shuai, Bihui Cao, Jinling Zhang, et al.. (2021). Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death and Disease. 12(3). 237–237. 79 indexed citations
11.
Xie, Huikang, Hang Su, Erjia Zhu, et al.. (2021). Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism. Frontiers in Oncology. 11. 608353–608353. 15 indexed citations
12.
Liang, Zhen, et al.. (2020). Effect of Micropapillary Pattern and Spread through Air Space in Patients with Lung Adenocarcinoma ≤ 2 cm. Journal of Cancer Therapy. 11(10). 597–604. 1 indexed citations
13.
Xu, Long, Hang Su, Yunlang She, et al.. (2020). Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer. CHEST Journal. 159(6). 2458–2469. 22 indexed citations
14.
Sun, Weiyan, Hang Su, Jinshi Liu, et al.. (2020). Impact of histological components on selecting limited lymphadenectomy for lung adenocarcinoma ≤ 2 cm. Lung Cancer. 150. 36–43. 10 indexed citations
15.
Deng, Jiajun, Yunlang She, Mengmeng Zhao, et al.. (2019). Simultaneously thoracoscopic resection of lung cancer and anterior mediastinal lesions by video-assisted thoracoscopic surgery. Annals of Translational Medicine. 7(14). 333–333. 8 indexed citations
16.
Liu, Jing, Bo Jin, Hang Su, Xiujuan Qu, & Yunpeng Liu. (2019). Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report. BMC Cancer. 19(1). 702–702. 33 indexed citations
17.
Ren, Yijiu, Liyan Zhang, Huikang Xie, et al.. (2018). Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma. Annals of Surgical Oncology. 25(13). 3812–3819. 7 indexed citations
18.
Dai, Chenyang, Huikang Xie, Hang Su, et al.. (2017). Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm. Journal of Thoracic Oncology. 12(7). 1052–1060. 145 indexed citations
19.
Jiang, Wenwei, et al.. (2016). A new method to diagnose discoid lateral menisci on radiographs. Knee Surgery Sports Traumatology Arthroscopy. 24(5). 1519–1524. 18 indexed citations
20.
Zeng, Xiaoyun, Jinhong Zheng, Chenglai Fu, et al.. (2013). A Newly Synthesized Sinapic Acid Derivative Inhibits Endothelial Activation In Vitro and In Vivo. Molecular Pharmacology. 83(5). 1099–1108. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026